Chronic pain in persons living with HIV (PLWH) may be related to alterations in endogenous pain modulatory processes (e.g., high facilitation and low inhibition of nociception) that promote exaggerated pain responses, known as hyperalgesia, and central nervous system (CNS) sensitization. This observational study examined differences in endogenous pain modulatory processes between 59 PLWH with chronic pain, 51 PLWH without chronic pain, and 50 controls without HIVor chronic pain. Quantitative sensory testing for temporal summation (TS) of mechanical and heat pain as well as conditioned pain modulation (CPM) were used to assess endogenous pain facilitatory and inhibitory processes, respectively. Associations among TS, CPM, and self-reported clinical pain severity were also examined in PLWH with chronic pain. Findings demonstrated significantly greater TS of mechanical and heat pain for PLWH with chronic pain compared to PLWH without chronic pain and controls. CPM effects were present in controls, but not in either PLWH with or without chronic pain. Among PLWH with chronic pain, greater TS of mechanical pain was significantly associated with greater average clinical pain severity. Results of this study suggest that enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain.
Introduction
Chronic pain is an important comorbidity that commonly affects persons living with HIV (PLWH). A recent review of the literature indicated that chronic pain may affect over half of all PLWH throughout their lifetimes, with increasing prevalence as these individuals age (Parker et al. 2014) . Peripheral neuropathy resulting from the neurotoxic effects of HIV itself as well as the medications used to treat HIV was widely considered the primary cause of chronic pain early in the antiretroviral treatment era (Dalakas 2001; Gabbai et al. 2013) . However, recent studies suggest a predominance of chronic musculoskeletal pain in PLWH that is non-neuropathic in nature (Jiao et al. 2016; Merlin et al. 2012a, b) . It is common for chronic pain in PLWH to be widespread, affecting multiple body locations (Miaskowski et al. 2011) . It is also becoming more widely appreciated that PLWH endure high-impact chronic pain that negatively impacts their ability to function and is associated with overall poor health outcomes. To illustrate, chronic pain in PLWH is associated with greater odds of functional impairment (Merlin et al. 2013) , increased health care service utilization (Dobalian et al. 2004) , suboptimal retention in HIV care (Merlin et al. 2012a, b) , and failure to achieve virologic suppression (Merlin et al. 2018) . Despite mounting evidence attesting to the physical and mental health consequences of chronic pain in PLWH, very little is currently known about the neurophysiological processes that may relate to the development and perpetuation of chronic pain in this population.
The percept of pain is greatly influenced by the endogenous processing of ascending (i.e., incoming) nociceptive signals from peripheral afferents, which are powerfully modulated by complex descending inhibitory and facilitatory processes within the central nervous system (CNS) (Ossipov et al. 2010; Ossipov et al. 2014) . The descending modulation of incoming nociceptive signals is manifested via pathways that originate at the level of the cerebral cortex, the thalamus, and the brainstem (Heinricher et al. 2009 ). Activation of these descending nociceptive modulatory processes often involves the release of inhibitory and/or excitatory neurotransmitters that can potently inhibit or facilitate the percept of pain, respectively (Staud 2013) . It has been suggested that the descending modulation of nociceptive signals within the CNS yields a pain inhibitory/facilitatory balance, which places individuals on a spectrum between antinociception and pronociception (Granovsky and Yarnitsky 2013; Yarnitsky et al. 2014) . To illustrate, an individual expressing diminished inhibition and enhanced facilitation would be positioned on the pronociceptive side of the spectrum. As a result, this individual would express a more pain-sensitive phenotype that increases the risk of developing (or worsening) a chronic pain condition. Conversely, an individual expressing efficient inhibition and non-enhanced facilitation would be positioned further on the antinociceptive side of the spectrum, and therefore express a less pain-sensitive phenotype that would help prevent the development of a chronic pain condition. The multiple, complex descending pathways involved in the modulation of nociceptive signals are referred to collectively as endogenous pain modulatory processes. The experience of chronic pain in PLWH may be related to alterations in endogenous pain modulatory processes (e.g., high facilitation and low inhibition of nociception) that promote hyperalgesia and CNS sensitization (Ossipov 2012; Staud 2012 Staud , 2013 . Initial support for this possibility comes from research previously conducted by our group comparing responses to noxious heat and mechanical stimuli between PLWH without comorbid chronic pain and controls without HIV. Results revealed that PLWH demonstrated significantly exaggerated pain responses to the noxious heat and mechanical stimuli compared to controls (Goodin et al. 2017) .
Experimental protocols designed to assess the endogenous inhibition or facilitation of pain are believed to better depict the clinical pain experience than the classical static parameters, such as pain thresholds (Yarnitsky et al. 2014) . A commonly used protocol for the assessment of pain inhibition is conditioned pain modulation (CPM), which refers to the reduction in pain from one stimulus (the test stimulus) produced by the application of a second pain stimulus at a remote body site (the conditioning stimulus) (Nir and Yarnitsky 2015) . CPM is believed to reflect the perceptual manifestation of diffuse noxious inhibitory controls (DNIC) (Le Bars 2002), whereby ascending projections from one noxious stimulus activate supraspinal structures that trigger descending inhibitory projections to the dorsal horn. The neurophysiological substrates that contribute to the CPM effect are thought to be opioidergic, serotonergic, and noradrenergic in nature (Ossipov et al. 2010; Ossipov et al. 2014; Staud 2013) . Characterization of temporal summation (TS) responses provides information about pain facilitation resulting from enhanced nociceptive processing in healthy individuals and those with chronic pain (Magerl et al. 1998; Price et al. 1977; Staud et al. 2014) . TS refers to an increase in pain perception after application of a series of identical noxious stimuli delivered at sufficient frequency and intensity (usually 0.3 Hz with fixed stimulus intensity). TS is presumed to be the psychophysical manifestation of wind-up (Staud et al. 2001) . Wind-up is a phenomenon where repetitive stimulation of C primary afferents at rates greater than 0.3 Hz produces a slowly increasing response of second-order neurons in the spinal cord (Magerl et al. 1998; Price et al. 1977) , which is dependent on activation of the N-methyl-D-aspartate (NMDA) receptors (Eide 2000) .
Typically, individuals with various chronic pain conditions demonstrate pronociceptive phenotypes expressed either as enhanced TS (facilitation), less efficient CPM (inhibition), or both (Staud 2012 (Staud , 2013 . The possibility of a pronociceptive phenotype in PLWH may be increased due to the direct effects of HIV itself on the CNS. HIV crosses the blood-brain barrier and damages neuronal tissue in the brain at least in part through NMDA receptor activation initiated by soluble neurotoxins from HIV-infected brain macrophages (O'Donnell et al. 2006; Spudich and Gonzalez-Scarano 2012) . NMDAmediated neuronal damage due to HIV infection may then alter endogenous pain modulatory processes that facilitate nociception, resulting in the percept of greater pain severity. However, no study to date has investigated whether chronic pain in PLWH is related to the endogenous pain modulatory processes using experimental pain protocols such as TS and CPM. The aim of the present study was to characterize differences in endogenous pain modulatory processes among PLWH with chronic pain, PLWH without chronic pain, and controls without HIV or chronic pain, as well as examine whether the endogenous pain modulatory processes represented by TS and CPM were associated with the clinical pain severity reported by PLWH with chronic pain. We hypothesized that (1) PLWH with chronic pain would demonstrate greater TS and less CPM compared to PLWH without chronic pain and controls, and (2) greater self-reported clinical pain severity would be associated with greater TS and less CPM for PLWH with chronic pain. This study represents an important first step toward elucidating the endogenous pain modulatory profiles of PLWH with chronic pain, which may reveal targets for future research and intervention.
Methods

Participants
A total of 110 PLWH were recruited from a large urban, HIV clinic in the southeast United States that provides comprehensive medical, behavioral, and social services to adults with HIV. Overall, this HIV clinic provides care to 3457 PLWH, of which 76% are men, 23% are women, and 1% is transgender. Further, 64% identify as Black/African American, 31% as White/ Caucasian, and 5% as Hispanic/Others. PLWH were separated into two groups according to their chronic pain status. We enrolled into this study 59 PLWH with chronic pain and 51 PLWH without chronic pain. Additionally, 50 individuals without HIV or chronic pain (controls) were also recruited from the local community via posted fliers and enrolled into the study. Each of these 160 total participants completed the study in its entirety. Study procedures were approved by our Institutional Review Board and carried out in accordance with guidelines for the ethical conduct of research. Written informed consent was obtained from each participant prior to the study and they were compensated a total of $100 for their involvement.
Overview of study design
A flow diagram depicting matriculation through the study is presented in Fig. 1 . PLWH with and without chronic pain and controls who were interested in being part of this study were assessed for eligibility during an initial telephone screening. A review of medical records was also completed for PLWH with and without chronic pain. Eligible participants then presented to the laboratory to complete a single study session that lasted approximately 2.5 h. At the beginning of this study session, participants completed resting blood pressure monitoring. They then underwent a tailored cold pressor task to determine the temperature of cold water that would be used for their CPM trials (see below). Next, participants completed standardized self-report measures to assess clinical pain severity, pain interference, pain catastrophizing, as well as depressive symptoms. These measures were followed by completion of a quantitative sensory testing battery which included TS of mechanical and heat pain as well as assessment of CPM. Sociodemographic information was collected from all participants and included age, sex, and racial background, as well as poverty status. Annual household income adjusted for number of occupants was used to determine poverty status according to 2017 guidelines put forth by the U.S. Department of Health and Human Services (Annual update of the HHS poverty guidelines 2017).
Telephone screening of inclusion/exclusion criteria
All interested individuals completed screening via telephone to determine eligibility for study inclusion. PLWH with chronic pain were included in this study only if they reported a pain problem that persisted for at least 3 months and resulted in pain on at least half the days in the past 6 months (Treede et al. 2015) . Furthermore, PLWH with chronic pain were only included if they denied any type of pain-alleviating surgery within the past year, or pain intervention (e.g., steroid injection) in the past month. PLWH without chronic pain were included in the study only if they denied any ongoing chronic pain problems and also denied any episodes of acute pain within the 2 weeks prior to study participation. Controls were included in the study only if they denied having any chronic pain condition and were HIV negative to the best of their knowledge. Additional inclusion criteria that needed to be met for all study participants were as follows: no evidence of uncontrolled hypertension (i.e., resting blood pressure > 150/95) assessed via sphygmomanometer during study session. This exclusionary criterion was included to prevent potentially unsafe rises in blood pressure produced by quantitative sensory testing. Also, no circulatory disorders, no history of cardiac events, no history of stroke or seizure, no history of metabolic disease, no ongoing cancer or related treatment, and not currently pregnant. A total of 65 PLWH with chronic pain were screened for study eligibility, while 59 were enrolled. Of the 55 PLWH without chronic pain who were screened for study eligibility, 51 were enrolled. Fifty controls were screened for eligibility and all were enrolled into the study. Of the ten PLWH who were not enrolled into the study, six were excluded due to uncontrolled hypertension, two for history of stroke, one for congestive heart failure, and one for recent history of cancer.
Medical record review
Medical record review was completed to determine whether PLWH were actively being prescribed antiretroviral therapy (ART), as well as any medications that could potentially affect endogenous pain modulation such as anti-depressants (Bannister and Dickenson 2016) or analgesics including opioids (Martini et al. 2015; Niesters et al. 2013) . Laboratory data including most recent absolute CD4+ T cell count, a measure of immune status, and most recent plasma HIV viral load were also obtained. Those participants with ≥ 50 copies of virus/mL were considered to have a detectable viral load; all others were considered virologically suppressed (i.e., without detectable viral loads). This cutoff (≥ 50) was selected due to its clinical relevance as an HIV treatment endpoint (Ryscavage et al. 2014; Sarmati et al. 2015) , and also because we have previously shown that even a small amount of detectable HIV in the blood may be sufficient to alter endogenous pain modulation (Goodin et al. 2017 ).
Study session
Tailored cold pressor At the very beginning of each participant's study session, a tailored cold pressor task was completed to determine the intensity of the conditioning stimulus that would be used in the CPM protocol to be completed during the subsequent quantitative sensory testing session. The use of a tailored cold pressor for CPM assessment is consistent with procedures previously published by our research team (Bulls et al. 2015; Owens et al. 2016 ). This was done by asking participants to fully immerse their non-dominant hand to the wrist three consecutive times in the cold water maintained at 16, 12, and 8°C. The water temperatures were maintained (± .05°C) by an ARTIC A25 refrigerated bath with an SC150 immersion circulator (ThermoFisher Scientific, USA) that constantly circulated the water to prevent local warming around the submerged hand (Edens and Gil 1995) . Ratings of pain intensity were obtained at 30 and 60 s after each immersion. Participants were provided with audio-recorded instructions regarding how to rate the intensity of the pain produced by the cold water on a 0-100 numeric rating scale, such that 0 = no pain and 100 = the most intense pain imaginable (Jensen and Karoly 1992) . The maximum duration of each hand immersion was 60 s and there was a 5-min rest period between each immersion. Following the tailoring procedure, the cold water temperature that produced a moderately intense pain rating of~50 (range 40-60) on the 0-100 numeric rating scale was selected for each participant as the conditioning stimulus for the completion of CPM trials.
Measures
Clinical pain severity and interference The Brief Pain Inventory (BPI)-Short Form is an 11-item multidimensional pain scale with demonstrated reliability in patients with neuropathic and musculoskeletal chronic pain conditions (Tan et al. 2004; Zelman et al. 2005 ). The BPI rates the severity of pain as well as the interference of pain. In this study, pain severity was assessed with four items asking about worst, least, and average pain in the last 24 h, as well as current pain Bright now.^These items are scored from 0 (no pain) to 10 (worst imaginable pain). Pain interference is the average of seven items (0 to 10 scale where 10 reflects Bcompletely interferes^) assessing the degree to which pain interferes with mood, physical activity, work/chores, social activity, relations with others, sleep, and enjoyment of life. Higher scores Fig. 1 Flow diagram representing matriculation of participants through the study suggest greater pain severity and interference, respectively. The BPI used in this study demonstrated good internal consistency (Cronbach's α = .89).
Pain catastrophizing The standard Pain Catastrophizing Scale (PCS) is a 13-item scale that assesses catastrophic thinking in response to pain (Sullivan et al. 1995) . The PCS assesses catastrophic pain-related cognitive-emotional processes by asking participants to recall their experiences during a past occurrence of pain. The PCS total score is calculated by summing the 13-item responses. Higher scores on the PCS are indicative of greater pain-related catastrophizing. In the current study, as is typically done in experimental pain studies, the standard PCS was administered before the initiation of quantitative sensory testing and was considered an assessment of individuals' tendency to engage in pain-related catastrophizing. The PCS total score, calculated by summing the 13-item responses, provides a good index of the catastrophizing construct through the inclusion of the highly correlated subscales of helplessness, rumination, and magnification. Higher scores on the PCS are indicative of greater pain-related catastrophizing. The internal consistency of the PCS in the current study was good (Cronbach's α = .85).
Depressive symptoms The Center for Epidemiological Studies-Depression Scale (CES-D) was used to measure depressive symptoms in this study. This 20-item measure assesses the frequency of experiencing depressive symptoms over the past week (0-never or rarely, to 3-most of the time/all the time). Symptoms of depression measured by the CES-D include negative mood, guilt/worthlessness, helplessness/hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance (Radloff 1977) . This measure has been shown to be reliable and valid in general populations, including when used in HIV and chronic pain populations (Geisser et al. 1997; Natamba et al. 2014) . Responses are summed (range 0-60), with higher scores indicating greater severity of depression. The CES-D measure used in the current study had good internal consistency (Cronbach's α = .89).
Quantitative sensory testing
PLWH with chronic pain who reported analgesic medication use including opioids were not asked to withhold these medications prior to completion of quantitative sensory testing given that temporary withdrawal from these medications could have affected pain perception. Instead, it was determined that analgesic medication use would be examined and statistically controlled in data analyses. All participants underwent a series of controlled sensory stimulation procedures to assess TS of mechanical and heat pain, as well as CPM (Starkweather et al. 2015) . TS of mechanical pain was always assessed prior to TS of heat pain, and the TS procedures were always completed prior to CPM. Before commencing this session, participants were again provided with audio-recorded instructions regarding how to rate the intensity of the pain produced by the mechanical and heat TS procedures on the 0-100 numeric rating scale.
Temporal summation of mechanical pain Temporal summation (TS) of mechanical pain was assessed using a nylon monofilament (Touchtest Sensory Evaluator 6.65) that was calibrated to bend at 300 g of pressure. Testing sites included the back of the non-dominant hand and the ipsilateral trapezius, in randomized order. To assess TS of mechanical pain at each site, participants were instructed to provide a verbal 0-100 rating of pain following a single contact of the monofilament. Then, participants were instructed to provide another 0-100 rating of their greatest pain intensity experienced following a series of ten contacts, which were provided at a rate of one contact per second. This procedure was repeated twice at each anatomical location. Pain ratings for the single and multiple contacts performed at each anatomical location were averaged across the two trials.
Temporal summation of heat pain TS of heat pain was assessed using a Medoc Thermal Sensory Analyzer-II (Medoc, Ltd., Ramat Yishai, Israel) with a 30 × 30-mm-diameter thermode. All participants completed three separate trials for the TS of heat pain procedure using 46, 48, and 50°C thermal stimuli. The thermode was placed at midline on the volar surface of the non-dominant forearm for the TS of heat pain trials. The thermode was moved approximately 2.5 cm up the forearm prior to commencing the second and third trials to prevent sensitization due to repeated testing; there was a 2-min rest period between each trial. For each trial, sequences of five consecutive heat pulses of 1-s duration were delivered with inter-pulse intervals of 2.5 s that were 40°C. For the TS of heat pain procedure, participants were asked to rate the intensity of the pain produced by each heat pulse on the 0-100 numeric rating scale.
Conditional pain modulation trials For this study, conditioned pain modulation (CPM) was tested on the dominant dorsal forearm and ipsilateral trapezius using algometry (test stimulus) and the cold pressor (conditioning stimulus) according to guidelines published by Yarnitsky and colleagues (Yarnitsky et al. 2010) . A handheld algometer (Medoc, Ltd., AlgoMed, Ramat Yishai, Israel) was alternately applied three times at each anatomical location, in counter-balanced fashion, to determine participants' baseline pressure pain thresholds (PPTs) (Ohrbach and Gale 1989) . Participants indicated when the increasing pressure stimulation first became painful, and PPTs were measured in kilopascals (kPa). Following baseline PPT determination, participants underwent a series of four cold pressor immersions that consisted of placing the non-dominant hand, up to the wrist, into the circulating cold water for 1 min. The cold pressor was maintained at the tailored temperature that produced a moderately painful sensation as determined at the beginning of the study session. Participants were told they could remove their hand from the water at any time; however, none of the participants prematurely removed their hand prior to the allotted 1 min for any of the four cold pressor immersions. Approximately 30 s after initiation of each cold pressor immersion, while the hand was still immersed, the algometer was used to deliver noxious mechanical stimulation to either the dorsal forearm (two CPM trials) or the ipsilateral trapezius (two CPM trials); the site order was randomized. Participants again indicated when the increasing pressure stimulation first became painful, which represented their conditioned PPTs. There was a 2-min rest period between each CPM trial.
Data reduction and analysis
All data were analyzed using SPSS, version 24 (IBM; Chicago, IL). All participants provided complete demographic and quantitative sensory testing data; however, a small portion of missing data existed for some of the self-report measures (< 5%). The missing data did not systematically vary between PLWH with and without chronic pain and controls, so it was deemed to be missing at random. Therefore, a simple data imputation method was completed using the macro for Hot Deck imputation (Myers 2011) . This data imputation method is well validated, readily accepted in the statistical community, and resulted in complete data for all of the study participants. Descriptive data for the sample are reported separately for PLWH with chronic pain, PLWH without chronic pain, and controls as either percentages or as means and standard deviations. Differences in descriptive data across the three study groups were assessed using Chisquare tests for categorical variables and one-way ANOVA for continuous variables. TS of mechanical and heat pain as well as CPM were tested using repeated measures ANOVA with Greenhouse-Geisser corrections. Statistical control variables were included in study analyses as warranted. Multiple comparisons across the three study groups were accounted for using the Holm-Bonferroni procedure to obtain corrected P values (Holm 1979) . Statistical presentation includes the squared partial eta (η p 2 ) as a measure of effect size where appropriate, such that η p 2 = .01 is considered a small effect, partial η p 2 = .06 a medium-sized effect, and η p 2 = .14 a large effect. Lastly, associations among study variables were assessed specifically in PLWH with chronic pain using zero-order correlations.
For the correlation analysis, endogenous pain modulation data obtained via TS and CPM testing were transformed into single continuous variables. TS indices for mechanical pain at the hand and trapezius were obtained by subtracting the pain intensity rating following a single contact with the mechanical stimulus from the pain intensity rating following ten contacts. For the index representing TS of heat pain, pain intensity ratings for the first heat pulse were subtracted from pain intensity ratings for the fifth heat pulse. CPM indices were created by subtracting baseline PPTs from conditioned PPTs for both the forearm and trapezius. These indices reflect the Δ change scores for TS of pain as well as CPM (Yarnitsky et al. 2010) , and they were subsequently included in the correlation analysis.
Results
Participant characteristics
Participant characteristics are shown in Table 1 . All participants were between the ages of 21 to 77 years and selfidentified as either Black/African American or White/ Caucasian. No other ethnic/racial group expressed interest in being enrolled into the study. Sex/gender (χ 2 = 13.48, p = .009), race (χ 2 = 26.10, p < .001), and poverty status (χ 2 = 58.12, p < .001) each significantly differed across the three study groups. Specifically, a greater proportion of the control group was comprised of women, White/Caucasians, and individuals living above the poverty line in comparison to PLWH with and without chronic pain. Sex/gender, race, and poverty status did not significantly differ between PLWH with and without chronic pain. Age did not significantly differ across study groups (F 2,157 = 0.86, p = .425). Medical records confirmed the HIV seropositive status for all 110 PLWH included in this study, and also revealed that 98% of both groups were actively receiving ART. The mean CD4 + across the entire sample was 668 cells/mL, while the proportion with a detectable viral load (> 50 copies/mL) was 25%. Neither CD4 + (F 1,108 = 0.26, p = .872) nor the proportion with a detectable viral load (χ 2 = 0.19, p = .667) significantly differed between PLWH with and without chronic pain. Review of medical records also revealed that 46 and 34% of the overall sample was actively being prescribed an anti-depressant or analgesic medication, respectively. The most commonly prescribed class of anti-depressant medication was selective serotonin reuptake inhibitors (48%), followed by atypical antidepressants (e.g., mirtazapine, trazadone) (26%), serotonin norepinephrine reuptake inhibitors (20%), and tricyclics (6%). The most commonly prescribed analgesics were nonsteroidal anti-inflammatory drugs (34%), followed by gabapentinoids (19%), combinations of analgesics (17%), opioids (15%), muscle relaxers (7%), and other (e.g., triptans for migraine) (8%). A significantly smaller proportion of controls were being prescribed anti-depressant (χ 2 = 46.92, p < .001) and analgesic (χ 2 = 35.35, p < .001) medications relative to PLWH with and without chronic pain. The proportion of PLWH with chronic pain actively prescribed antidepressant medication did not significantly differ from that of PLWH without chronic pain; however, a significantly greater proportion of PLWH with chronic pain were actively prescribed an analgesic medication compared to PLWH without chronic pain. Depressive symptoms (F 2,157 = 18.84, p < .000) and pain catastrophizing (F 2,157 = 40.26, p < .000) both significantly differed across the three study groups, such that PLWH with chronic pain reported greater severity of depressive symptoms and greater pain catastrophizing compared to PLWH without chronic pain and controls. Among PLWH with chronic pain, the most frequently reported primary pain location was low back (44%), hips/knees (30%), neck (9%), widespread (3+ distinct sites) (9%), shoulder/arm/hand (4%), and feet (4%). Average chronic pain intensity was reportedly 6.4 out of 10, and ranged from 4.6 (least) to 7.2 (worst) over the past 24 h. At the time of study session, PLWH with chronic pain reported their pain Bright now^to be 6.1. Pain interference was suggestive of moderate impact on daily functioning with an average rating of 5.6 out of 10.
Correlations, group differences, and selection of covariates BPI-pain interference --5.6 (2.5)
CES-D Center for Epidemiological Studies Depression Scale, PCS pain catastrophizing scale, BPI brief pain inventory
The purpose of these analyses was to select appropriate covariates for inclusion in subsequent multivariable models. Across the entire sample, Black/African Americans 1 Contact = pain intensity rating in response to first contact with mechanical stimuli, 10 contact = pain intensity rating in response to 10 contacts with mechanical stimuli; 1st pulse = pain intensity rating for first heat pulse, 5th pulse = pain intensity rating for 5th heat pulse , and viral load were not associated with any endogenous pain modulatory variable and thus not included as covariates in any analyses.
Differences in temporal summation of mechanical pain
For TS of mechanical pain, the pain intensity rating elicited by the first contact with the nylon monofilament was compared to the rating elicited following the series of ten contacts; this was done at both the hand and trapezius. Data representing TS of mechanical pain are presented in Table 2 . Adjusted results show that PLWH with chronic pain demonstrated significantly greater TS of mechanical pain at the hand (F 2,150 = 5.86, p = .004; η p 2 = .072) and trapezius (F 2,150 = 4.77, p = .011; η p 2 = .060) in comparison to PLWH without chronic pain and controls. Specifically, the magnitude (i.e., slope) of TS for mechanical pain stimuli was greater at both body sites for PLWH with chronic pain relative to PLWH without chronic pain and controls (Fig. 2, panels a and b) . Results remained significant after applying the HolmBonferroni adjustment. TS of mechanical pain did not significantly differ at either body site between PLWH without chronic pain and controls.
Differences in temporal summation of heat pain
For TS of heat pain, the pain intensity rating elicited by the first heat pulse was compared to the rating elicited by the fifth heat pulse for the 46, 48, and 50°C stimuli assessed at the nondominant volar forearm. Data representing TS of heat pain are also presented in Table 2 . Adjusted results show that PLWH with chronic pain demonstrated significantly greater TS of heat pain at 46°C (F 2,150 = 15.39, p < .001; η p 2 = .170) and 48°C (F 2,150 = 11.51, p < .001; η p 2 = .133) compared to PLWH without chronic pain and controls. Specifically, the magnitude (i.e., slope) of TS for the 46 and 48°C heat stimuli was greater for PLWH with chronic pain compared to PLWH without chronic pain and controls (Fig. 3, panels a and b) . Findings remained significant after applying the Holm-Bonferroni adjustment for multiple comparisons. TS of heat pain at 46 and 48°C did not significantly differ between PLWH without chronic pain and controls. In response to the 50°C stimulus, TS of heat pain did not significantly differ across the three study groups (F 2150 = 1.53, p = .220; η p 2 = .021). However, as can be seen in Fig. 3 , panel C, ratings of pain intensity in response to each of the five 50°C heat pulses were significantly higher for PLWH with chronic pain compared to PLWH without chronic pain and controls (F 2,150 = 8.02, p < .001; η p 2 = .097).
Differences in conditioned pain modulation
For CPM, baseline PPTs were compared to conditioned PPTs (i.e., PPTs assessed during concurrent cold pressor application) at both the forearm and trapezius. As demonstrated in Table 3 , controls demonstrated significantly greater CPM effects (i.e., the change between baseline and conditioned PPTs) at the forearm (F 2,150 = 3.91, p = .022; η p 2 = .049) and trapezius (F 2,150 = 3.14, p = .046; η p 2 = .040) in comparison to PLWH with chronic pain or PLWH without chronic pain. More specifically, controls demonstrated significant CPM effects while both PLWH with and without chronic pain demonstrated a lack of significant CPM effects (Fig. 4 , panels a and b). Results remained significant after applying the HolmBonferroni adjustment. Taken together, this evidence suggests an overall lack of efficient pain inhibition for both PLWH with chronic pain and PLWH without chronic pain. The temperature of the water used to test CPM did not significantly differ across PLWH with and without chronic pain and controls (χ 2 = 7.81, p = .100).
Associations among endogenous pain modulatory processes and clinical pain severity
Pearson correlations are shown in the Table 4 and variable associations among only the PLWH with chronic pain. Results revealed that ratings of greater average pain severity on the BPI were significantly correlated with greater TS of mechanical pain at the hand (r = .298, p = .022) and trapezius (r = .336, p = .009). None of the other associations between TS, CPM, and the clinical pain severity variables were significant. Pain catastrophizing and depressive symptoms were each consistently and significantly correlated with greater clinical pain severity and greater pain interference.
Discussion
This study examined the endogenous pain modulatory balance of PLWH with chronic pain by including TS and CPM protocols for the assessment of pain inhibitory and facilitatory processes, respectively. Study protocols used for TS and CPM were consistent with commonly recommended methods (Cruz-Almeida and Fillingim 2014; Yarnitsky et al. 2010; Yarnitsky et al. 2015) . PLWH with chronic pain demonstrated pronociceptive endogenous pain modulatory profiles characterized by high facilitation and low inhibition. Specifically, TS of mechanical and heat pain (at 46 and 48°C) were significantly greater in PLWH with chronic pain compared to PLWH without chronic pain and controls without HIV or chronic pain. There was no evidence of significant CPM for either PLWH with or without chronic pain; therefore, they did not differ from one another in regard to CPM. However, control participants demonstrated significant CPM effects at both the forearm and trapezius. TS of mechanical pain was significantly associated with greater average clinical pain severity for PLWH with chronic pain. Taken together, our results lend support to the idea that alterations in endogenous pain modulatory processes may be an important contributor to the development and/or experience of chronic pain for PLWH. For both mechanical and heat TS, PLWH with chronic pain reported significantly greater pain in response to the final stimulus application compared to the first despite the stimulus intensity remaining the same across each respective procedure. TS of pain has been a widely incorporated test of pronociceptive endogenous pain facilitation in previous studies (Yarnitsky 2015) ; however, no published study to date has examined TS of pain in PLWH with chronic pain. The enhanced endogenous pain facilitation (i.e., TS of pain) found in our study may be indicative of central nervous system (CNS) sensitization (Woolf 2011) . This is because endogenous pain facilitatory pathways are particularly important in initiating and maintaining CNS sensitization (Latremoliere and Woolf 2009 ). Our group has previously shown that PLWH report decreased pain thresholds, decreased pain tolerances, and increased pain responses to experimental noxious stimuli consistent with CNS sensitization (Goodin et al. 2017) . Chronic pain is maintained in part by CNS sensitization, which refers to a phenomenon of synaptic plasticity and increased neuronal responsiveness in central pain pathways after painful insults. Mounting evidence suggests that the pronociceptive endogenous pain facilitatory processes that initiate and maintain CNS sensitization are driven by neuroinflammation in the peripheral and central nervous system (Ji et al. 2018) . Sustained release of cytokines and chemokines in the CNS may promote sensitization by tipping the endogenous pain modulatory balance in the pronociceptive direction (i.e., by promoting pain facilitation while abating pain inhibition). Such a cascade of events is particularly relevant for PLWH because pre-clinical and clinical studies have shown that envelope proteins such as GP120, found on the surface of HIV, initiate neuroinflammation by activating astrocytes and microglia in the CNS (Holguin et al. 2004; Yuan et al. 2014) .
That TS of mechanical pain, but not TS of heat pain, was significantly associated with greater average clinical pain severity for PLWH with chronic pain is consistent with findings from previous studies conducted by our group in patients with chronically painful musculoskeletal conditions including knee osteoarthritis (Goodin et al. 2014 ) and low back pain (Owens et al. 2016 ). In the current study, low back (44%) and hips/ knees (30%) represented almost three quarters of the primary pain locations reported by PLWH with chronic pain. Given the presumed musculoskeletal origin of this chronic pain, the clinical pain experiences of PLWH are possibly mechanically evoked (e.g., trunk flexion, postural perturbations, gait alterations) (Griffith et al. 2012) . Therefore, the mechanical stimuli used to test TS of pain may be more clinically relevant than other modalities such as heat. Given that we have now demonstrated TS of mechanical pain, but not TS of heat pain, to be associated with clinical pain severity across three entirely different studies including this one with PLWH, a potential clinical application for TS of mechanical pain is becoming increasingly apparent. The simple procedure for assessing TS of mechanical pain in this study could easily be included in clinical practice to help identify patients with amplified pain sensitivity who may require a more intensive, multidisciplinary approach to their chronic pain management. Unlike TS of heat pain assessment, which requires costly equipment and methodologies that are technically elaborate and time consuming, TS of mechanical pain assessment with a nylon monofilament is relatively brief, inexpensive, and requires minimal technical expertise (Goodin et al. 2014) .
Our hypothesis that PLWH with chronic pain would demonstrate less efficient CPM compared to PLWH without chronic pain and controls was partially supported. The concurrent cold pressor pain had a significant conditioning effect on pressure pain thresholds for controls, which is indicative of efficient endogenous pain inhibition for individuals without HIV or chronic pain. Conversely, PLWH with chronic pain did not demonstrate any conditioning effect of the cold pressor on their pressure pain thresholds, which suggests an absolute lack of endogenous pain inhibition (i.e., CPM). Lack of CPM in PLWH with chronic pain was expected and consistent with our first hypothesis. However, contrary to what was hypothesized, PLWH without chronic pain also demonstrated lack of a significant CPM effect. This lack of CPM effect in PLWH without chronic pain may represent a risk factor for the future development of chronic pain. Recent findings suggest that diminished endogenous inhibitory control is likely to be an important element in determining whether pain becomes chronic (Ossipov et al. 2014) . The inability to engage a robust endogenous pain inhibitory system may leave PLWH vulnerable and susceptible to a chronic pain condition.
It is noteworthy that PLWH with chronic pain reported more catastrophic thoughts about pain and depressive symptoms than PLWH without chronic pain and controls. Furthermore, findings from the correlational analysis also revealed that pain catastrophizing and depressive symptoms were each significantly associated with greater clinical pain severity (e.g., worst pain, least pain, pain right now) and greater pain interference for PLWH with chronic pain. This finding is consistent with previous work whereby pain catastrophizing and depression were shown to be correlated with increased pain-related disability and ART side-effects, respectively, in PLWH with painful neuropathy (Lucey et al. 2011) . Negative thoughts about pain, including helplessness and thoughts similar to catastrophizing, have been associated with interference in daily functional activities, overall emotional distress, and affective symptoms in HIV patients reporting neuropathic pain (Evans et al. 2003; Griswold et al. 2005) . Taken together, All PPT scores are presented as kilopascals (kPa) initial evidence suggests that pain catastrophizing and depression are likely related to poor clinical pain outcomes in PLWH. Although not directly supported in the current study, prior work has also demonstrated that pain catastrophizing and depression are associated with enhanced endogenous pain facilitation and dampened pain inhibition (Goodin et al. 2009 Nahman-Averbuch et al. 2016; Rhudy et al. 2011) . For this reason, pain catastrophizing and depression have been described as psychological risk factors associated with alterations in endogenous pain facilitatory and inhibitory processes that maintain or aggravate CNS sensitization (Quartana et al. 2009; van Wilgen et al. 2018) . Importantly, cognitivebehavioral therapies for chronic pain management have been shown to be effective for mitigating the negative effects of pain catastrophizing and depression (Ehde et al. 2014 ).
Whether such psychologically based therapies might improve chronic pain and related CNS sensitization for PLWH by diminishing pain catastrophizing and depressive symptoms is a topic for further research. Several limitations should be considered when evaluating the findings of this study. First, interpretation of the clinical relevance of this study is limited by the cross-sectional nature of the study design. At this time, we cannot determine whether the alterations in endogenous pain modulatory processes presented in this study were a determinant or consequence of chronic pain development in PLWH. Future longitudinal studies are needed to determine whether enhanced endogenous pain facilitation and/or diminished pain inhibition predict the development of chronic pain in PLWH. Second, although the classification of chronic pain used in this study conformed to the recently published standards put forth by the International Association for the Study of Pain Task Force for the Classification of Chronic Pain (Treede et al. 2015) , we did not systematically obtain information related to potential pathoanatomical underpinnings of chronic pain in PLWH (e.g., avascular necrosis, small fiber neuropathy, non-specific). Thus, different etiological underpinnings for chronic pain may have been present in this sample, and it is unclear whether this potentially impacted tests of endogenous pain modulatory processes. Third, the alterations in endogenous pain modulatory processes presented in this study are consistent with previous findings observed in non-HIV samples with chronic pain conditions including fibromyalgia (O'Brien et al. 2018) , osteoarthritis , and irritable bowel syndrome (Piche et al. 2010) , among others. It is not possible to determine from the current study whether HIV promotes chronic pain by playing a specific role in altering these endogenous pain modulatory processes, or whether alterations in endogenous pain modulatory mechanisms represents a shared chronic pain correlate across populations with and without HIV. Additional research in humans is needed to determine whether HIV might specifically alter endogenous pain modulatory processes through the purported proliferation of neuroinflammation, for example. Lastly, controls were asked to self-report their negative HIV status; however, we did not confirm this with blood tests.
In conclusion, the findings from this study provide novel evidence for an endogenous pain modulatory balance that is associated with the promotion of chronic pain in PLWH when dynamic tests of TS (facilitation) and CPM (inhibition) are used. The findings lend support to an endogenous pain modulatory balance characterized by enhanced pain facilitatory processes assessed via TS of mechanical and heat stimuli, as well as diminished pain inhibitory processes tested via CPM methodology. TS of mechanical pain may have particular clinical relevance for PLWH, given associations with average clinical pain severity found in this study and others conducted by our group. Additionally, PLWH with chronic pain reported greater pain catastrophizing and depressive symptoms compared to PLWH without chronic pain. Evidence suggests that pain catastrophizing and depression are important psychological factors associated with increased disability in chronic pain populations (Arnow et al. 2006; Quartana et al. 2009 ). Thus, it will be important moving forward for clinically focused research and treatment to address the mental, as well as physical, health of PLWH with chronic pain.
